These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18270542)

  • 1. BCG revaccination does not protect against leprosy in the Brazilian Amazon: a cluster randomised trial.
    Cunha SS; Alexander N; Barreto ML; Pereira ES; Dourado I; Maroja Mde F; Ichihara Y; Brito S; Pereira S; Rodrigues LC
    PLoS Negl Trop Dis; 2008 Feb; 2(2):e167. PubMed ID: 18270542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of the leprosy component of the Brazilian BCG revaccination trial for assessing BCG effectiveness against leprosy in school children.
    Cunha SS; Dourado I; Barreto ML; Alexander N; Pereira SM; Ichihara Y; Pereira ES; Pedrosa V; Maroja F; Ribas C; Rodrigues LC
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):8-15. PubMed ID: 15217320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal BCG protection against leprosy: a study in Manaus, Brazilian Amazon.
    Cunha SS; Rodrigues LC; Pedrosa V; Dourado IM; Barreto ML; Pereira SM
    Lepr Rev; 2004 Dec; 75(4):357-66. PubMed ID: 15682973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial.
    Rodrigues LC; Pereira SM; Cunha SS; Genser B; Ichihara MY; de Brito SC; Hijjar MA; Dourado I; Cruz AA; Sant'Anna C; Bierrenbach AL; Barreto ML
    Lancet; 2005 Oct; 366(9493):1290-5. PubMed ID: 16214599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial.
    Barreto ML; Pereira SM; Pilger D; Cruz AA; Cunha SS; Sant'Anna C; Ichihara MY; Genser B; Rodrigues LC
    Vaccine; 2011 Jul; 29(31):4875-7. PubMed ID: 21616115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of single-dose rifampicin after BCG vaccination to prevent leprosy in close contacts of patients with newly diagnosed leprosy: A cluster randomized controlled trial.
    Richardus R; Alam K; Kundu K; Chandra Roy J; Zafar T; Chowdhury AS; Nieboer D; Faber R; Butlin CR; Geluk A; Richardus JH
    Int J Infect Dis; 2019 Nov; 88():65-72. PubMed ID: 31499206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.
    Pereira SM; Barreto ML; Pilger D; Cruz AA; Sant'Anna C; Hijjar MA; Ichihara MY; Santos AC; Genser B; Rodrigues LC
    Lancet Infect Dis; 2012 Apr; 12(4):300-6. PubMed ID: 22071248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
    Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of the Brazilian BCG-REVAC trial against tuberculosis: a large, simple randomized community trial to evaluate the impact on tuberculosis of BCG revaccination at school age.
    Barreto ML; Rodrigues LC; Cunha SS; Pereira S; Hijjar MA; Ichihara MY; de Brito SC; Dourado I
    Control Clin Trials; 2002 Oct; 23(5):540-53. PubMed ID: 12392870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi.
    Glynn JR; Dube A; Fielding K; Crampin AC; ; Kanjala C; Fine PEM
    Lancet Infect Dis; 2021 Nov; 21(11):1590-1597. PubMed ID: 34237262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long lasting BCG protection against leprosy.
    Rodrigues LC; Kerr-Pontes LR; Frietas MV; Barreto ML
    Vaccine; 2007 Sep; 25(39-40):6842-4. PubMed ID: 17728023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi.
    Pönnighaus JM; Fine PE; Sterne JA; Wilson RJ; Msosa E; Gruer PJ; Jenkins PA; Lucas SB; Liomba NG; Bliss L
    Lancet; 1992 Mar; 339(8794):636-9. PubMed ID: 1347338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
    Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of intradermal BCG against leprosy; a case-control study in central Brazil.
    Rodrigues ML; Silva SA; Neto JC; de Andrade AL; Martelli CM; Zicker F
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):335-9. PubMed ID: 1474274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The protective efficacy of BCG against leprosy in São Paulo, Brazil].
    Lombardi C; Pedrazzani ES; Pedrazzani JC; Ferreira Filho P; Zicker F
    Bol Oficina Sanit Panam; 1995 Nov; 119(5):415-21. PubMed ID: 8540997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results.
    Convit J; Sampson C; Zúñiga M; Smith PG; Plata J; Silva J; Molina J; Pinardi ME; Bloom BR; Salgado A
    Lancet; 1992 Feb; 339(8791):446-50. PubMed ID: 1346818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCG vaccination of children against leprosy in Uganda: final results.
    Stanley SJ; Howland C; Stone MM; Sutherland I
    J Hyg (Lond); 1981 Oct; 87(2):233-48. PubMed ID: 7288177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ILEP organisations should strive for high BCG coverage in communities at risk of leprosy.
    Velema JP; Ogbeiwi OI
    Lepr Rev; 2007 Jun; 78(2):88-101. PubMed ID: 17824479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study.
    Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR
    Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG vaccination of children against leprosy: seven-year findings of the controlled WHO trial in Burma.
    Bechelli LM; Garbajosa PG; Gyi MM; Uemura K; Sundaresan T; Martínez Domínguez V; Matejka M; Tamondong C; Quagliato R; Engler V; Altmann M
    Bull World Health Organ; 1973; 48(3):323-34. PubMed ID: 4270384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.